Viewing Study NCT03979066


Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2026-01-25 @ 5:01 AM
Study NCT ID: NCT03979066
Status: TERMINATED
Last Update Posted: 2020-12-23
First Post: 2019-06-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study Evaluating NEOadjuvant Immunotherapy in Resectable PANCreatic Ductal Adenocarcinoma
Sponsor: Gulam Manji
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Ductal Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neoadjuvant therapy View
None PEGPH20 View
None Atezolizumab View
None Columbia View
None Pancreatic Ductal Adenocarcinoma View